VA NATIONAL ACQUISITION CENTER APPROVES CONTRACT AWARD FOR INGEN
-Department of Veterans Affairs Federal Supply Schedule ContractAward for Ingen-
--Ingen Technologies, Inc. (PinkSheets: IGNT.PK), an ISO 13485:2003 certified medical device manufacturer ofrespiratory medical devices announced today that the company has received a Departmentof Veterans Affairs Federal Supply Scheduled Contract Award beginning on April1, 2011 and ending on March 31, 2016.
OnMarch 24, 2011 the company received a Contract Award Letter from the VANational Acquisition Center. The company was provided a copy of the FederalSupply Schedule Contract V797P-4379b, effective April 1, 2011 through March 31,2016, for items awarded under 65IIA under the Medical Equipment and SuppliesFederal Supply Schedule Solicitation 797-FSS-99-0025-R6.
"Wesubmitted the 'GSA' application with the VA national Acquisition Center inSeptember of 2009. With this contract award, we are able to sell ourrespiratory products to VA Hospitals and other government related medicalfacilities. Our new SMART Nasal Cannula which uses our Oxyview technology wasintroduced to the VA Hospitals last year through our strategic partnership withKGMA Business Solutions. Various government facilities expressed seriousinterest in the purchase of our respiratory products for their home carepatients that are prescribed oxygen therapy." stated Gary Tilden, Chairmanand COO.
AboutIngen:
Our wholly owned subsidiary is an established ISO certified medicaldevice manufacturer with an emerging new medical product line for therespiratory market worth an estimated $4 Billion in the US, and $8 billionglobally. Visit www.ingen-tech.com.
Safe Harbor for Forward-Looking Statements: This news releaseincludes forward-looking statements. While these statements are made toconvey to the public the company’s progress, business opportunities and growthprospects, readers are cautioned that such forward-looking statements representmanagement’s opinion. Whereas management believes such representations tobe true and accurate based on information and data available to the company atthis time, actual results may differ materially from those described. Thecompany’s operations and business prospects are always subject to risk anduncertainties. Important factors that may cause actual results to differare and will be set forth in the company’s periodic filings withthe U.S. Securities and Exchange Commission.